基本信息
浏览量:64
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr.Zhang’s research focuses on developing synthetic nanoplatforms to direct immune cells as ‘living therapeutics’. To this end, his laboratory integrates materials science, immunology, synthetic biology, and translational medicine to create novel nanotherapeutics for controlled modulation of the immune system. The overarching goal of his research is to establish a fundamental understanding of nanotherapeutic design and the ways it interacts with the immune system. The ultimate goal of his research is to translate nanomedicine to the clinic. Dr.Zhang’s laboratory seeks to create a unique working environment by fostering interdisciplinary and translational collaboration. The current research focuses include: (1) engineering synthetic nanoplatforms; (2) engineering synthetic cell-based therapy; (3) physiology-guided drug delivery.
研究兴趣
论文共 62 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Chad A. Littrell,Gregory P. Takacs, Chenikkayala Siva Sankara,Alexandra Sherman, Kai A. Rubach,Julia S. Garcia, Coral Bell,Jeffrey K. Harrison,Fan Zhang
biorxiv(2024)
Jennifer I Bennett, Mary O'Kelly Boit,Nicole E Gregorio,Fan Zhang,Ryan D Kibler, Jack W Hoye, Olivia Prado,Peter B Rapp,Charles E Murry,Kelly R Stevens,Cole A DeForest
Advanced science (Weinheim, Baden-Wurttemberg, Germany)no. 24 (2024): e2301708-e2301708
Kevon J Jolly,Fan Zhang
Advances in pharmacology (San Diego, Calif.) (2024): 247-288
PROGRESS IN ORGANIC COATINGS (2024): 108365
Corrosion Science (2024): 112274
Advanced drug delivery reviews (2023): 114827-114827
Journal for immunotherapy of cancerno. 6 (2023): e006533-e006533
Journal of controlled release : official journal of the Controlled Release Society (2023): 27-42
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn